What is Kura Oncology's interest income and other, net?

Kura Oncology (KURA) reported interest income and other, net of $5.83M in Q1 2026.

How has Kura Oncology's interest income and other, net changed year-over-year?

Kura Oncology's interest income and other, net decreased by 26.1% year-over-year, from $7.88M to $5.83M.

What is the long-term trend for Kura Oncology's interest income and other, net?

Over 4 years (2021 to 2025), Kura Oncology's interest income and other, net has grown at a 117.1% compound annual growth rate (CAGR), from $1.21M to $26.77M.

Kura Oncology KURA Interest income and other, net

Interest income and other, net at other companies

Tyra Biosciences, Inc.TYRA

——

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$919.7M+81.6%

Enterprise value$904.89M+90.7%

P/S12.8×+3.5×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's interest income and other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's interest income and other, net?: Kura Oncology (KURA) reported interest income and other, net of $5.83M in Q1 2026.
How has Kura Oncology's interest income and other, net changed year-over-year?: Kura Oncology's interest income and other, net decreased by 26.1% year-over-year, from $7.88M to $5.83M.
What is the long-term trend for Kura Oncology's interest income and other, net?: Over 4 years (2021 to 2025), Kura Oncology's interest income and other, net has grown at a 117.1% compound annual growth rate (CAGR), from $1.21M to $26.77M.